Vytrus Biotech SA
MAD:VYT

Watchlist Manager
Vytrus Biotech SA Logo
Vytrus Biotech SA
MAD:VYT
Watchlist
Price: 5.25 EUR 2.94%
Market Cap: 40.1m EUR

Intrinsic Value

The intrinsic value of one VYT stock under the Base Case scenario is 3.64 EUR. Compared to the current market price of 5.25 EUR, Vytrus Biotech SA is Overvalued by 31%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

VYT Intrinsic Value
3.64 EUR
Overvaluation 31%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Vytrus Biotech SA

What is Valuation History?
Compare VYT to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about VYT?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Vytrus Biotech SA
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Vytrus Biotech SA

Balance Sheet Decomposition
Vytrus Biotech SA

Current Assets 3.8m
Cash & Short-Term Investments 2.5m
Receivables 726.5k
Other Current Assets 538.1k
Non-Current Assets 7.3m
Long-Term Investments 85.3k
PP&E 856.5k
Intangibles 4.1m
Other Non-Current Assets 2.3m
Efficiency

Free Cash Flow Analysis
Vytrus Biotech SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Vytrus Biotech SA

Revenue
5m EUR
Cost of Revenue
-902.4k EUR
Gross Profit
4.1m EUR
Operating Expenses
-3.1m EUR
Operating Income
1m EUR
Other Expenses
7.6k EUR
Net Income
1m EUR
Fundamental Scores

VYT Profitability Score
Profitability Due Diligence

Vytrus Biotech SA's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Healthy Operating Margin
Positive ROE
57/100
Profitability
Score

Vytrus Biotech SA's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

VYT Solvency Score
Solvency Due Diligence

Vytrus Biotech SA's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
High Altman Z-Score
Long-Term Solvency
73/100
Solvency
Score

Vytrus Biotech SA's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VYT Price Targets Summary
Vytrus Biotech SA

There are no price targets for VYT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Vytrus Biotech SA
does not pay dividends
Shareholder Yield

Current shareholder yield for VYT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one VYT stock?

The intrinsic value of one VYT stock under the Base Case scenario is 3.64 EUR.

Is VYT stock undervalued or overvalued?

Compared to the current market price of 5.25 EUR, Vytrus Biotech SA is Overvalued by 31%.

Back to Top